Anti-MKK7 antibody [EP1455Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Recombinant Monoclonal MKK7 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Rat, Mouse samples. Cited in 15 publications.
View Alternative Names
JNKK2, MEK7, MKK7, PRKMK7, SKK4, MAP2K7, Dual specificity mitogen-activated protein kinase kinase 7, MAP kinase kinase 7, MAPKK 7, JNK-activating kinase 2, MAPK/ERK kinase 7, Stress-activated protein kinase kinase 4, c-Jun N-terminal kinase kinase 2, MEK 7, SAPK kinase 4, SAPKK-4, SAPKK4, JNK kinase 2, JNKK 2
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-MKK7 antibody [EP1455Y] (AB52618)
Intracellular Flow Cytometry analysis ofMCF7 (Human breast adenocarcinoma epithelial cell) cells labeling MKK7 with ab52618at 1/100 dilution (1μg) (Red). Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody. Cells were fixed with4% paraformaldehyde. Rabbit monoclonal IgG (ab172730) was used as isotype control (Black). Unlabelled control : Cells without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MKK7 antibody [EP1455Y] (AB52618)
ab52618 at 1/50 dilution staining human baldder tissue; paraffin embedded.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-MKK7 antibody [EP1455Y] (AB52618)
Lanes 1, 5 and 9 : Wild-type HAP1 cell lysate (20 μg)
Lanes 2, 6 and 10 : MEK7 knockout HAP1 cell lysate (20 μg)
Lanes 3, 7 and 11 : HeLa cell lysate (20 μg)
Lanes 4, 8 and 12 : A431 cell lysate (20 μg)
Lanes 1, 2, 3 and 4 : Green signal from target - ab52618 observed at 47 kDa
Lanes 5, 6, 7 and 8 : Red signal from loading control - ab8245 observed at 37 kDa
Lanes 9, 10, 11 and 12 : Merged (red and green) signal
ab52618 was shown to specifically react with MEK7 when MEK7 knockout samples were used. Wild-type and MEK7 knockout samples were subjected to SDS-PAGE. ab52618 and ab8245 (loading control to GAPDH) were diluted 1/10 000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-MKK7 antibody [EP1455Y] (ab52618)
Predicted band size: 47 kDa
false
- WB
Unknown
Western blot - Anti-MKK7 antibody [EP1455Y] (AB52618)
All lanes:
Western blot - Anti-MKK7 antibody [EP1455Y] (ab52618) at 1/10000 dilution
All lanes:
HeLa cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP antibody at 1/2000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-MKK7 antibody [EP1455Y] (AB52618)
Dilution and blocking buffer : 5% NFDM/TBST.
Low expression control : mouse and rat skeletal muscle.
In Western blot, anti-Vinculin antibody (ab129002) loading control staining at 1/10000 dilution.
All lanes:
Western blot - Anti-MKK7 antibody [EP1455Y] (ab52618) at 1/1000 dilution
Lane 1:
Mouse testis tissue lysate at 20 µg
Lane 2:
Mouse brain tissue lysate at 20 µg
Lane 3:
Mouse skeletal muscle tissue lysate (Low expression control) at 20 µg
Lane 4:
Rat testis tissue lysate at 20 µg
Lane 5:
Rat brain tissue lysate at 20 µg
Lane 6:
Rat skeletal muscle tissue lysate (Low expression control) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 47 kDa
false
Exposure time: 15s
Related conjugates and formulations (2)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MKK7 antibody [EP1455Y]
-
Anti-MKK7 antibody [EP1455Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MKK7 plays an essential role in the activation of the JNK (c-Jun N-terminal kinases) signaling pathway by phosphorylating and activating JNK. It operates as part of a signaling complex that responds to stress stimuli. This kinase is involved in numerous cellular processes such as apoptosis differentiation and inflammatory responses. The regulation of these processes by MKK7 impacts many aspects of cellular homeostasis and response to environmental changes.
Pathways
MKK7 is integrally involved in the stress-activated MAPK pathway and the cellular response to inflammatory cytokines. It closely collaborates with related proteins such as JNK1 JNK2 and JNK3 to mediate its downstream effects. Activation of this pathway leads to the modulation of gene expression that governs cell survival proliferation and other critical cellular functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1317 PubMed40817125
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:1052 PubMed35217669
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34502457
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer chemotherapy and pharmacology 86:361-374 PubMed32776229
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cachexia, sarcopenia and muscle 11:1104-1120 PubMed32096609
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 12:23 PubMed32116652
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 152:221-234 PubMed31390677
2019
Applications
Unspecified application
Species
Unspecified reactive species
Human pathology 86:143-154 PubMed30537492
2018
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology letters 290:36-45 PubMed29567110
2018
Applications
WB
Species
Rat
The Journal of biological chemistry 293:3965-3980 PubMed29352108
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com